Market Size of Europe Medical Simulation Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Historical Data Period | 2019 - 2022 |
CAGR | 12.70 % |
Market Concentration | High |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Europe Medical Simulation Market Analysis
The Europe Medical Stimulation market is expected to register a CAGR of 12.7% over the forecast period.
The outbreak of the COVID-19 pandemic has pushed the medical device industry into action, with a race to develop both therapeutic and preventive devices. Exponentially increasing cases of the coronavirus worldwide are leading to the need for the development of novel treatments, with several clinical trials underway. Meanwhile, the manufacturers of medical devices were highly focused on developing vaccines and drugs, which can also be applied in the diagnosis and treatment of COVID-19, increasing the rate of clinical trials to a great extent. During COVID-19 many companies in Europe have taken initiatives to continue the education of medical stimulation without any disruption. For instance, during the pandemic, VirtaMed initiated numerous tours to support continued medical stimulation education and arranged workshops for residents across Switzerland, France, and Germany. The company also launched a new way of supplying medical training with the latest healthcare simulation solutions in 2020. It was also Switzerland's first mobile surgical simulation lab to deliver risk-free training to the doors of university hospitals and toured for three months. The mobile surgical simulation lab was equipped with the latest mixed reality simulators and has traveled over 2,000 kilometers around Switzerland. The laboratory also visited a total of 16 Swiss university hospitals as well. Therefore, such instances indicate that the market witnessed a considerable growth during the pandemic.
The continuous technological advancements, increasing concerns over patient safety, and increasing demand for minimally invasive treatments are the major drivers for the market growth. For instance, as per the report of Global Obesity Observatory 2021, 24.5% men were obese and 43.8% were overweight in Germany in 2020. Therefore, owing to such percentages the National Obesity Risk predicted was 7/10 which was much higher and an issue of concern for Germany in 2021. Thus, such a scenario has increased the awareness about obesity in Germany owing to which majority of the people are opting for minimally invasive aesthetic surgeries for weight loss. This factor is fueling the demand for aesthetic devices across the country. The use of stimulation techniques in minimally invasive surgeies improves the patient safety thus, majority of the surgeons are utilizing such techniques in minimally invasive surgeries. Therefore, such factors are anticipated to propel the market growth over the forecast period.
However, high cost of simulators and reluctant to adopt new training methods are likely to hinder the market growth over the forecast period.